Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 25601342

Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2015 Feb
First author
Bradley JD

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2015 Feb;16(2):125-7. doi: 10.1016/S1470-2045(15)70001-X.
    note
    Source null
    related pmid
    25601340
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2015 Apr;16(4):e156-7. doi: 10.1016/S1470-2045(15)70121-X.
    note
    Source null
    related pmid
    25846093
    relationship
    Comment in

Authors and identifiers

  1. name
    Bradley JD
    type
    Author
  2. name
    Paulus R
    type
    Author
  3. name
    Komaki R
    type
    Author
  4. name
    Masters G
    type
    Author
  5. name
    Blumenschein G
    type
    Author
  6. name
    Schild S
    type
    Author
  7. name
    Bogart J
    type
    Author
  8. name
    Hu C
    type
    Author
  9. name
    Forster K
    type
    Author
  10. name
    Magliocco A
    type
    Author
  11. name
    Kavadi V
    type
    Author
  12. name
    Garces YI
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Bradley JD
    type
    Author
  2. name
    Paulus R
    type
    Author
  3. name
    Komaki R
    type
    Author
  4. name
    Masters G
    type
    Author
  5. name
    Blumenschein G
    type
    Author
  6. name
    Schild S
    type
    Author
  7. name
    Bogart J
    type
    Author
  8. name
    Hu C
    type
    Author
  9. name
    Forster K
    type
    Author
  10. name
    Magliocco A
    type
    Author
  11. name
    Kavadi V
    type
    Author
  12. name
    Garces YI
    type
    Author
bibliography ids
  1. nci-bib-a9dc9d3a3576a931f758ab5e
book metadata
content sha256
604a31b3355bbb9bded0eb63f352e017bc1bf0fc09ace8761e5ecce808c73cba
document type
citation
dois
  1. 10.1016/S1470-2045(14)71207-0
electronic publication date
display
2015 Jan 16
precision
day
year
2015
evidence scope
bibliographic_metadata_only
id
pubmed:25601342
immutable id
pubmed:25601342@604a31b3355bbb9bded0eb63f352e017bc1bf0fc09ace8761e5ecce808c73cba
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
2
name
The Lancet. Oncology
nlm unique id
100957246
pages
187-99
volume
16
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2015 Feb;16(2):125-7. doi: 10.1016/S1470-2045(15)70001-X.
    note
    Source null
    related pmid
    25601340
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2015 Apr;16(4):e156-7. doi: 10.1016/S1470-2045(15)70121-X.
    note
    Source null
    related pmid
    25846093
    relationship
    Comment in
outcomes validated
false
pmid
25601342
provenance
batch id
863b068fe5a07222af6a
provider
NCBI PubMed ESummary
record sha256
7c498990878bf637acaaa02b8b3084bb73d6ded08b0bad1e9fde8f46a5b4cab5
response sha256
80b1cc99e93fcfceb3e1b12ea433c615b032a2db13a615db7a6e9382c17c5034
retrieved at
2026-09-09T23:47:07.648963+00:00
publication date
display
2015 Feb
precision
month
year
2015
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, N.I.H., Extramural
  7. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/25601342/
title
Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.

Preserved source evidence · Not medical advice